Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_assertion type Assertion NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_head.
- NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_assertion description "[The significantly higher AR/alphaSGT ratio in metastatic samples is consistent with the sensitization of prostate tumor cells to androgen signaling with disease progression, particularly in a low-hormone environment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_provenance.
- NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_assertion evidence source_evidence_literature NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_provenance.
- NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_assertion SIO_000772 17942943 NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_provenance.
- NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_assertion wasDerivedFrom befree-2016 NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_provenance.
- NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_assertion wasGeneratedBy ECO_0000203 NP635910.RA53n_f3XuTDIL7Vgq4GWQs6hCo7dCrdPClCalgpyopi4130_provenance.